| Database ID | Symbol | Body Site | Sample Type | Sample Name | Microbe | Project ID | AS Type | Group | Chr | PSI Visulization | Splicing Variant | Details |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2090614 | TMEM134 | Blood | Tissue | PSC-derived alveolar epithelial type II-like cells | Control/Healthy;COVID-19 | GSE152418 | A3SS | G0/G1 | 11 | - |
PV=1 FDR=1 FC=0.18 |
|
| 2090615 | TMEM134 | Blood | Tissue | PSC-derived alveolar epithelial type II-like cells | Control/Healthy;COVID-19 | GSE152418 | A3SS | G0/G1 | 11 | - |
PV=0.219 FDR=1 FC=-0.011 |
|
| 2090616 | TMEM134 | Blood | Tissue | PSC-derived alveolar epithelial type II-like cells | Control/Healthy;COVID-19 | GSE152418 | A3SS | G0/G1 | 11 | - |
PV=0.005 FDR=0.252 FC=-0.061 |
|
| 2090617 | TMEM134 | Blood | Tissue | PSC-derived alveolar epithelial type II-like cells | Control/Healthy;COVID-19 | GSE152418 | A3SS | G0/G1 | 11 | - |
PV=0.114 FDR=1 FC=-0.055 |
